benserazide (Serazide)

Introduction

available in Europe

Indications

• used in conjunction with levodopa for treatment of Parkinson's disease

Pharmacokinetics

• does not cross blood-brain barrier

Mechanism of action

• dopa-decarboxylase inhibitor

More general terms

• aromatic amino acid
• catecholamine
• pharmacologic agents for treatment of Parkinson's disease
• enzyme inhibitor

Additional terms

• carbidopa (Lodosyn)

Database

• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=2327
• PubChem: http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=26964